cloudyn.png
Wednesday January 20th, 2021 1:09AM

Guided Therapeutics Makes Final Payment to GPB Capital Holdings for Secured Notes

By The Associated Press

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Jan 13, 2021--

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had made the final payment of $750,000 to GPB Capital Holdings, LLC under a cash and equity exchange agreement signed on January 16, 2020. Under the agreement, once the agreed upon cash payments were made, the remaining debt owed to GPB was converted into equity. The final payment also removed any and all security interests over the Company’s assets previously held by GPB and sets all warrants held by GPB at a fixed price, thereby eliminating them as a liability on the Company’s balance sheet. In all, between the cash payment, the equity exchange and the removal of the warrants as a liability, the final $750,000 payment to GPB results in a total of $5,070,000 of liabilities removed from the Company’s balance sheet, compared with the end of the third quarter 2020.

“We are extremely pleased that we were able to make the final payment to GPB and that our assets are no longer encumbered by debt,” said Gene Cartwright, CEO of Guided Therapeutics. “Over the past two years, we have reduced our liabilities significantly to a manageable level and can now plan on growing the business without making large debt related monthly payments.”

Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company’s first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: .

Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics’ actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading “Risk Factors” in Guided Therapeutics’ reports filed with the SEC, including Guided Therapeutics’ Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and subsequent filings.

View source version on businesswire.com:

CONTACT: Mark Faupel

Guided Therapeutics

770-242-8723

KEYWORD: UNITED STATES NORTH AMERICA GEORGIA

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES CONSUMER WOMEN RESEARCH SCIENCE BIOTECHNOLOGY

SOURCE: Guided Therapeutics

Copyright Business Wire 2021.

PUB: 01/13/2021 09:05 AM/DISC: 01/13/2021 09:05 AM

http://www.businesswire.com/news/home/20210113005196/en

  • Associated Categories: Associated Press (AP), AP Online - Georgia News, AP Business Wire - Georgia
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
NYC to terminate Trump contracts after Capitol insurrection
Mayor Bill de Blasio says New York City will terminate business contracts with President Donald Trump after last week’s insurrection at the U.S. Capitol
9:26AM ( 11 minutes ago )
US COVID-19 deaths hit another one-day high at over 4,300
Coronavirus deaths in the U.S. have hit another one-day high at over 4,300 with the country’s attention focused largely on the fallout from the deadly uprising at the Capitol
9:24AM ( 13 minutes ago )
UK's Johnson pledges vaccine program to operate 24-7
Prime Minister Boris Johnson has vowed that Britain's coronavirus vaccine program will operate around the clock seven days a week “as soon as we can,” as the U.K. accelerates efforts to inoculate millions of its most vulnerable people
9:22AM ( 15 minutes ago )
Associated Press (AP)
Georgia could take back vaccine from slow-moving providers
Georgia Gov. Brian Kemp is again urging patience among people waiting to be vaccinated against the coronavirus even as he threatens to take vaccines away from large hospital systems that his administration says aren’t moving fast enough to administer the shots
7:29PM ( 14 hours ago )
Masters plans for a limited number of spectators in April
Augusta National plans to have cheers, but maybe not roars at the Masters in April
6:06PM ( 15 hours ago )
Supreme Court wrestles with Georgia college free speech case
The Supreme Court is weighing whether to revive a lawsuit brought by a Georgia college student who sued school officials after being prevented from distributing Christian literature on campus
2:33PM ( 19 hours ago )
AP Online - Georgia News
AP Business Wire - Georgia
NYC to terminate Trump contracts after Capitol insurrection
Mayor Bill de Blasio says New York City will terminate business contracts with President Donald Trump after last week’s insurrection at the U.S. Capitol
9:26AM ( 11 minutes ago )
US COVID-19 deaths hit another one-day high at over 4,300
Coronavirus deaths in the U.S. have hit another one-day high at over 4,300 with the country’s attention focused largely on the fallout from the deadly uprising at the Capitol
9:24AM ( 13 minutes ago )
UK's Johnson pledges vaccine program to operate 24-7
Prime Minister Boris Johnson has vowed that Britain's coronavirus vaccine program will operate around the clock seven days a week “as soon as we can,” as the U.K. accelerates efforts to inoculate millions of its most vulnerable people
9:22AM ( 15 minutes ago )
Kremlin foe Navalny says he will fly home despite threats
Top Kremlin critic Alexei Navalny says he will fly home to Russia over the weekend despite the Russian prison service’s latest motion to put him behind bars for allegedly breaching the terms of his suspended sentence and probation
9:08AM ( 29 minutes ago )
World warily watches America's postelection aftershocks
For America’s allies and rivals alike, the chaos unfolding during Donald Trump’s final days as president is the logical result of four years of global instability brought on by the man who promised to change the way the world viewed the United States
9:05AM ( 32 minutes ago )